AAAAAA
Results:
1-12
|
Results: 12
Authors:
BHATNAGAR A
DOWSETT M
SANTEN D
SMITH I
BOEHM R
LONNING P
TEDESCHI M
LASSUS M
MILLER B
TOMINAGA T
Citation: A. Bhatnagar et al., PHARMACOLOGICAL PROFILE OF AN IDEAL AROMATASE INHIBITOR IN THE TREATMENT OF BREAST-CANCER - DISCUSSION OF SESSION 2, Breast cancer research and treatment, 49, 1998, pp. 73-77
Authors:
TEDESCHI M
SALVESEN B
Citation: M. Tedeschi et B. Salvesen, SONGS ON STONE - WHISTLER,JAMES,MCNEILL AND THE ART OF LITHOGRAPHY (CHICAGO EXHIBITION), Museum studies, 24(1), 1998, pp. 21-136
Authors:
SMYTH JF
BOWMAN A
PERREN T
WILKINSON P
PRESCOTT RJ
QUINN KJ
TEDESCHI M
Citation: Jf. Smyth et al., GLUTATHIONE REDUCES THE TOXICITY AND IMPROVES QUALITY-OF-LIFE OF WOMEN DIAGNOSED WITH OVARIAN-CANCER TREATED WITH CISPLATIN - RESULTS OF A DOUBLE-BLIND, RANDOMIZED TRIAL, Annals of oncology, 8(6), 1997, pp. 569-573
Authors:
TEDESCHI M
Citation: M. Tedeschi, WHISTLER AND THE ENGLISH PRINT MARKET -PRINTS( ETCHINGS, LITHOGRAPHS,REPRODUCTIVE), Print quarterly, 14(1), 1997, pp. 15-41
Authors:
TEDESCHI M
SCIAKY R
Citation: M. Tedeschi et R. Sciaky, TOWARDS A REVISION OF THE ITALIAN MITOSTOMA .1. SUBDIVISION IN GROUPSAND DESCRIPTION OF NEW SPECIES (ARACHNIDA, OPILIONES, NEMASTOMATIDAE), Revue Suisse de Zoologie, 104(3), 1997, pp. 503-516
Authors:
CAVALETTI G
CASCINU S
VENTURINO P
TEDESCHI M
TREDICI G
Citation: G. Cavaletti et al., NEUROPROTECTANT DRUGS IN CISPLATIN NEUROTOXICITY, Anticancer research, 16(5B), 1996, pp. 3149-3159
Authors:
COLOMBO N
BINI S
MICELI D
BOGLIUN G
MARZORATI L
CAVALETTI G
PARMIGIANI F
VENTURINO P
TEDESCHI M
FRATTOLA L
BURATTI C
MANGIONI C
Citation: N. Colombo et al., WEEKLY CISPLATIN+ -GLUTATHIONE IN RELAPSED OVARIAN-CARCINOMA/, International journal of gynecological cancer, 5(2), 1995, pp. 81-86
Authors:
ZECCA E
MARTINI C
VENTURINO P
TEDESCHI M
VENTAFRIDDA V
DECONNO F
Citation: E. Zecca et al., EFFICACY OF MEGESTROL-ACETATE ON ANOREXIA IN PATIENTS WITH ADVANCED NON HORMONE-RELATED TUMORS - A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL, European journal of cancer, 31A, 1995, pp. 1253-1253
Authors:
PARNIS FX
COLEMAN RE
HARPER PG
PICKERING D
TOPHAM C
WHITTINGTON JR
TEDESCHI M
Citation: Fx. Parnis et al., A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL ASSESSINGTHE TOLERABILITY AND EFFICACY OF GLUTATHIONE AS AN ADJUVANT TO ESCALATING DOSES OF CISPLATIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, European journal of cancer, 31A(10), 1995, pp. 1721-1721
Authors:
CAMAGGI CM
STROCCHI E
MARTONI A
ZAMAGNI C
CACCIARI N
DELLACUNA GR
PAVESI L
TEDESCHI M
SILVA A
PANNUTI F
Citation: Cm. Camaggi et al., PHARMACOKINETIC EVALUATION OF 2 DIFFERENT FORMULATIONS OF MEGESTROL-ACETATE IN PATIENTS WITH ADVANCED MALIGNANCIES, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 356-359
Authors:
TREDICI G
CAVALETTI G
PETRUCCIOLI MG
FABBRICA D
TEDESCHI M
VENTURINO P
Citation: G. Tredici et al., LOW-DOSE GLUTATHIONE ADMINISTRATION IN THE PREVENTION OF CISPLATIN-INDUCED PERIPHERAL NEUROPATHY IN RATS, Neurotoxicology, 15(3), 1994, pp. 701-704
Authors:
LOCATELLI MC
DANTONA A
LABIANCA R
VINCI M
TEDESCHI M
CARCIONE R
CORBO A
VENTURINO P
LUPORINI G
Citation: Mc. Locatelli et al., A PHASE-II STUDY OF COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH CISPLATIN AND CYCLOPHOSPHAMIDE PLUS REDUCED GLUTATHIONE AS POTENTIAL PROTECTIVE AGENT AGAINST CISPLATIN TOXICITY, Tumori, 79(1), 1993, pp. 37-39
Risultati:
1-12
|